Dasatinib tablets 50mg “JG” is a generic formulation containing Dasatinib, a tyrosine kinase inhibitor used to treat Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) and Ph+ acute lymphoblastic leukemia (ALL). It is supplied as 50mg 1 tablet and has YJ code 4291020F2031.
Dasatinib tablets 50mg “JG”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
